MedTrace Logo

Personalized, Transdiagnostic Approach to Preventative Mental Health

NCT03946319 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-05-14

No results posted yet for this study

Summary

This study is investigating the self-report adherence and assessment completion rates when presented with a transdiagnostic, partial assessment multiple times a day when compared with a monotopic, complete assessment once a day. Specifically, the investigators are testing the hypothesis that the personalization of diagnostic assessment topics and timing will lead to improved self-report regiment adherence rates, assessment completion rates, and total assessments completed during the study period. The study does not test the efficacy of the personalized assessments as a diagnostic instrument, there is no clinical decision support provided to clinicians during this study, and there is no treatment provided during this study.

Conditions

  • Mental Health
  • Mental Disorders
  • Delivery of Health Care
  • Self-Assessment
  • Diagnosis, Psychiatric

Interventions

DIAGNOSTIC_TEST

Introspect Health

Introspect Health is a software platform which has implemented both the monotopic and personalized, transdiagnostic assessment tools. The software is delivered via the internet using a mobile device or computer.

Sponsors & Collaborators

  • Introspect Health

    lead INDUSTRY

Principal Investigators

  • Anne M Huffman, PhD · California Institute of Integral Studies

  • Michael K Owens · Introspect Health

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-31
Primary Completion
2019-08-31
Completion
2019-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03946319 on ClinicalTrials.gov